查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年慢性病管理市場預測：按類型、疾病類型、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383405

到 2030 年慢性病管理市場預測：按類型、疾病類型、最終用戶和地區進行的全球分析

Chronic Disease Management Market Forecasts to 2030 - Global Analysis By Type, Disease Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球慢性病管理市場規模為 63 億美元，預計在預測期內將以 13.8% 的年複合成長率成長，到 2030 年達到 156 億美元。

慢性病管理市場是一個處理糖尿病、心臟病和癌症等長期非傳染性疾病的醫療保健部門。它包括旨在預防、監測和治療這些疾病以改善患者生活品質的各種策略和技術。應用包括遠端患者監測、個體化治療計劃和資料驅動的主導。

根據 NCBI 的數據，慢性病約佔死亡原因的 60% 和全球疾病負擔的 43%。

人口高齡化加劇

隨著人口結構轉向老化趨勢轉變，慢性病的盛行率正在增加。這種人口趨勢給醫療保健系統和資源帶來了巨大壓力，需要加強疾病管理策略。對慢性病的專業照護、預防措施和長期支持的需求不斷增加，推動了客製化醫療解決方案和技術的發展。解決人口高齡化的醫療保健需求不僅會改善老年人的生活品質，而且在提供有效和高效的護理、推動慢性病管理市場的成長方面也變得越來越重要。

實施先進的計劃是昂貴的

最尖端科技、遠端監控系統和個體化治療解決方案的開發和實施往往需要大量的財務投資。醫療保健組織和提供者經常面臨預算限制以及分配資源來部署昂貴技術的挑戰。此外，這些費用可能會增加患者負擔並限制獲得先進的慢性病管理。經濟負擔也會阻礙小型醫療機構和服務不足的社區提供全面的疾病管理服務，從而加劇健康差距。減少這些成本障礙對於確保公平獲得有效的慢性病管理解決方案至關重要。

政府醫療保健政策和獎勵

世界各地許多政府都認知到慢性病增加對經濟和公共衛生的影響。因此，我們實施了鼓勵開發和採用創新疾病管理解決方案的政策。獎勵包括財政支持、報銷計劃和法律規範，以促進將技術和遠端醫療涵蓋衛生系統，並使提供者更容易提供有效的慢性病管理服務。此類政策不僅促進市場成長，還有助於改善醫療保健的可及性、降低醫療保健成本並改善患者的治療效果，為醫療相關人員和患者創造雙贏的局面。

嚴格的法規和合規要求

法規對於確保病患安全和資料安全至關重要，但過於複雜和限制性的法規環境會抑制創新，並可能阻礙管理慢性病的新技術和解決方案的快速開發和部署。合規性挑戰會增加將產品推向市場的時間和成本，並為公司和醫療保健提供者製造障礙。此外，複雜的法規環境可能會阻礙市場進入、限制競爭並限制先進慢性病管理解決方案的使用，最終影響病患照護和醫療保健系統，影響效率。

COVID-19 的影響：

COVID-19 的疫情對慢性病管理市場產生了重大影響。由於醫療保健系統專注於應對這一流行病，常規慢性病護理已被打亂。遠端醫療和遠端監控解決方案越來越受到關注，以最大限度地減少現場就診並降低弱勢群體的暴露風險。然而，由於資源被轉用於與大流行相關的配合措施，並且常規篩檢和治療被推遲，未控制的慢性病的數量可能會增加，引發人們對長期健康影響的擔憂。這場大流行加速了數位健康解決方案的採用，並凸顯了對有彈性和適應性的慢性病管理策略的需求。

在預測期內，服務業預計將是最大的。

預計服務業市場將出現良好成長。該市場的服務包括廣泛的醫療保健服務，旨在滿足患有長期健康問題的個人的需求。這些服務包括疾病預防和教育、診斷測試、治療計劃、藥物管理和生活方式諮詢。醫療保健提供者正在利用遠端監控、遠端醫療諮詢和資料主導干涉等技術來提供以患者為中心的護理，以有效追蹤和管理慢性病。支持團體和心理健康服務在解決慢性病患者的情緒和心理方面也發揮著重要作用。

預計糖尿病產業在預測期內年複合成長率最高

預計糖尿病領域在預測期內將以最快的年複合成長率成長。由於其廣泛盛行率和綜合管理的需要，糖尿病已成為慢性病的焦點。這種以高血糖值為特徵的慢性疾病需要持續監測、生活方式調整，通常還需要藥物和胰島素治療。醫療保健提供者和數位健康解決方案提供各種服務，包括血糖監測設備、糖尿病教育計劃、個人化用餐和運動計劃以及遠距醫療諮詢。目的是幫助糖尿病患者更好地管理他們的病情，降低併發症的風險並提高他們的整體生活品質。

佔比最高的地區

預計北美市場在預測期內將繼續佔據大部分市場佔有率。該地區包括美國和加拿大，高齡化、文明病和慢性病負擔的增加正在推動對創新疾病管理解決方案的需求。遠端醫療、穿戴式裝置和電子健康記錄擴大被採用，從而實現遠端監控和個人化護理。此外，在北美，政府政策和醫療保健法規經常鼓勵慢性病管理計劃的製定和實施，從而促進醫療保健創新的發展，重點是改善患者的治療結果和減少慢性病的經濟影響。 。

複合年複合成長率最高的地區：

預計亞太地區在預測期內年複合成長率最高。該地區人口眾多、中階不斷壯大以及生活方式的改變正在增加糖尿病、心血管疾病和呼吸系統疾病等慢性病的盛行率。醫療保健提供者和技術公司正在積極推出疾病預防、監測和治療的創新解決方案。遠端醫療服務、行動健康應用程式和遠端監控設備越來越受歡迎，尤其是在中國和印度等國家。政府旨在改善醫療保健可近性和提高患者對管理慢性病重要性的認知的配合措施正在促進市場擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球慢性病管理市場：依類型

  • 解決方案
    • 本地解決方案
    • 雲端基礎的解決方案
    • 基於網路的
  • 服務
    • 諮詢服務
    • 實施服務
    • 教育服務
  • 其他類型

第6章 全球慢性病管理市場：依疾病類型

  • 心血管疾病
  • 糖尿病
  • 癌症
  • 氣喘
  • 慢性阻塞性肺病
  • 其他類型的疾病

第7章 全球慢性病管理市場：依最終使用者分類

  • 醫療服務提供方
  • 醫療保健付款人
  • 其他最終用戶

第8章 全球慢性病管理市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • HealthSmart Holdings, Inc.
  • Vivify Health, Inc
  • Medecision, Inc.
  • Pegasystems Inc.
  • Allscripts Healthcare Solutions, Inc.
  • Altruista Health
  • AxisPoint Health
  • Epic Corporation Inc.
  • TriZetto Corporation
  • EXL Healthcare
  • ZeOmega Inc.
  • Health Catalyst
Product Code: SMRC24254

According to Stratistics MRC, the Global Chronic Disease Management Market is accounted for $6.3 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 13.8% during the forecast period. The Chronic Disease Management Market is the healthcare sector dedicated to addressing long-term, non-communicable health conditions such as diabetes, heart disease, and cancer. It involves a range of strategies and technologies aimed at preventing, monitoring, and treating these conditions to improve patients' quality of life. Its uses include remote patient monitoring, personalized treatment plans, and data-driven interventions.

According to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden.

Market Dynamics:

Driver:

Increasing of aging population

As demographics shift towards an older populace, there is a heightened prevalence of chronic diseases, as many of these conditions become more common with age. This demographic trend places a substantial burden on healthcare systems and resources, necessitating enhanced disease management strategies. The demand for specialized care, preventive measures, and long-term support for chronic illnesses is on the rise, fostering the development of tailored healthcare solutions and technologies. Addressing the healthcare needs of the aging population not only improves their quality of life but also drives the growth of the chronic disease management market as it becomes increasingly essential in providing effective and efficient care.

Restraint:

Implementations of advanced programs are expensive

Developing and deploying cutting-edge technologies, remote monitoring systems, and personalized treatment solutions often require substantial financial investments. Healthcare organizations and providers may be constrained by budget limitations and face challenges in allocating resources for the adoption of expensive technologies. Additionally, these costs can translate to higher expenses for patients, limiting their access to advanced chronic disease management. The financial burden may also deter smaller healthcare facilities and underserved regions from offering comprehensive disease management services, potentially exacerbating health disparities. Mitigating these cost barriers is essential to ensure equitable access to effective chronic disease management solutions.

Opportunity:

Government healthcare policies and incentives

Many governments worldwide are recognizing the economic and public health implications of rising chronic disease burdens. As a result, they are implementing policies that encourage the development and adoption of innovative disease management solutions. Incentives may include financial support, reimbursement programs, and regulatory frameworks that promote the integration of technology and telehealth into healthcare systems, making it easier for providers to offer effective chronic disease management services. These policies not only stimulate market growth but also contribute to better access to care, reduced healthcare costs, and improved patient outcomes, creating a win-win scenario for healthcare stakeholders and patients alike.

Threat:

Stringent regulations and compliance requirements

While regulations are essential for ensuring patient safety and data security, an overly complex and restrictive regulatory environment can impede innovation and hinder the rapid development and deployment of new technologies and solutions for managing chronic diseases. Compliance challenges can increase the time and cost of bringing products to market, creating barriers for businesses and healthcare providers. Additionally, navigating a complex regulatory landscape may deter some companies from entering the market, limiting competition and potentially limiting the availability of advanced chronic disease management solutions, ultimately impacting patient care and healthcare system efficiency.

COVID-19 Impact:

The COVID-19 pandemic has had a profound impact on the Chronic Disease Management Market. With healthcare systems focused on responding to the pandemic, there has been a disruption in routine chronic disease care. Telemedicine and remote monitoring solutions gained prominence to minimize in-person visits and reduce exposure risks for vulnerable populations. However, the diversion of resources towards pandemic-related efforts and delays in routine screenings and treatments has led to a potential increase in unmanaged chronic conditions, which may have long-term health implications. The pandemic has accelerated the adoption of digital health solutions while highlighting the need for resilient and adaptable chronic disease management strategies.

The services segment is expected to be the largest during the forecast period

The services segment is expected to have lucrative growth in the market. Services in the market encompass a wide range of healthcare offerings tailored to address the needs of individuals dealing with long-term health conditions. These services include disease prevention and education, diagnostic testing, treatment planning, medication management, and lifestyle counseling. Healthcare providers offer patient-centered care by leveraging technology for remote monitoring, telehealth consultations, and data-driven interventions to track and manage chronic diseases effectively. Support groups and mental health services also play a vital role in addressing the emotional and psychological aspects of living with a chronic condition.

The diabetes segment is expected to have the highest CAGR during the forecast period

The diabetes segment is anticipated to witness the fastest CAGR growth during the forecast period. Diabetes is a central focus in the chronic disease, given its widespread prevalence and the need for comprehensive management. This chronic condition, characterized by high blood sugar levels, requires ongoing monitoring, lifestyle adjustments, and often medication or insulin therapy. Healthcare providers and digital health solutions offer a range of services, including glucose monitoring devices, diabetic education programs, personalized dietary and exercise plans, and telehealth consultations. The goal is to empower individuals with diabetes to better manage their condition, reduce the risk of complications, and improve their overall quality of life.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region encompasses the United States and Canada, where the aging population, lifestyle-related diseases, and the rising burden of chronic illnesses drive the demand for innovative disease management solutions. The adoption of telehealth, wearable devices, and electronic health records is widespread, enabling remote monitoring and personalized care. Additionally, government policies and healthcare regulations in North America often encourage the development and implementation of chronic disease management programs, making it a fertile ground for healthcare innovation, with a focus on improving patient outcomes and reducing the economic impact of chronic diseases.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's significant population, rising middle class and lifestyle changes have led to an increasing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders. Healthcare providers and technology companies are actively introducing innovative solutions for disease prevention, monitoring, and treatment. Telehealth services, mobile health apps, and remote monitoring devices are gaining traction, especially in countries like China and India. Government initiatives to improve healthcare access and the growing awareness among patients about the importance of managing chronic conditions contribute to the market's expansion.

Key players in the market

Some of the key players in Chronic Disease Management market include: HealthSmart Holdings, Inc., Vivify Health, Inc, Medecision, Inc., Pegasystems Inc., Allscripts Healthcare Solutions, Inc., Altruista Health, AxisPoint Health, Epic Corporation Inc., TriZetto Corporation, EXL Healthcare, ZeOmega Inc. and Health Catalyst.

Key Developments:

In January 2023, MedStar Health and Zephyr AI, Inc. a start-up specializing in precision medicine technology announced their partnership to work to improve outcomes for chronic diseases, beginning with type 2 diabetes (T2D).

In October 2022, Enli Health Intelligence, a supplier of digital solutions for population health management, was acquired by Cedar Gate Technologies. With the addition of cohort, population, and patient management technologies, risk & quality indicators, gaps in care identification, and patient outreach opportunities, Cedar Gate's enterprise value-based care platform was intended to be expanded for improved outcomes and long-term financial viability.

Types Covered:

  • Solutions
  • Services
  • Other Types

Disease Types Covered:

  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • Asthma
  • Chronic Obstructive Pulmonary Disorders
  • Other Disease Types

End Users Covered:

  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Chronic Disease Management Market, By Type

  • 5.1 Introduction
  • 5.2 Solutions
    • 5.2.1 On-Premise Solution
    • 5.2.2 Cloud-Based Solution
    • 5.2.3 Web-Based
  • 5.3 Services
    • 5.3.1 Consulting Services
    • 5.3.2 Implementation Services
    • 5.3.3 Educational Services
  • 5.4 Other Types

6 Global Chronic Disease Management Market, By Disease Type

  • 6.1 Introduction
  • 6.2 Cardiovascular Diseases
  • 6.3 Diabetes
  • 6.4 Cancer
  • 6.5 Asthma
  • 6.6 Chronic Obstructive Pulmonary Disorders
  • 6.7 Other Disease Types

7 Global Chronic Disease Management Market, By End User

  • 7.1 Introduction
  • 7.2 Healthcare Providers
  • 7.3 Healthcare Payers
  • 7.4 Other End Users

8 Global Chronic Disease Management Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 HealthSmart Holdings, Inc.
  • 10.2 Vivify Health, Inc
  • 10.3 Medecision, Inc.
  • 10.4 Pegasystems Inc.
  • 10.5 Allscripts Healthcare Solutions, Inc.
  • 10.6 Altruista Health
  • 10.7 AxisPoint Health
  • 10.8 Epic Corporation Inc.
  • 10.9 TriZetto Corporation
  • 10.10 EXL Healthcare
  • 10.11 ZeOmega Inc.
  • 10.12 Health Catalyst

List of Tables

  • Table 1 Global Chronic Disease Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 4 Global Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 5 Global Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 6 Global Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 7 Global Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 8 Global Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 9 Global Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 10 Global Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 11 Global Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 12 Global Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 13 Global Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 14 Global Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 15 Global Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 16 Global Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 17 Global Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 18 Global Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 19 Global Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 21 Global Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 22 Global Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 26 North America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 27 North America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 28 North America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 29 North America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 30 North America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 31 North America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 32 North America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 33 North America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 34 North America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 35 North America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 36 North America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 37 North America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 38 North America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 39 North America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 40 North America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 41 North America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 43 North America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 44 North America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 48 Europe Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 49 Europe Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 50 Europe Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 51 Europe Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 52 Europe Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 53 Europe Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 54 Europe Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 55 Europe Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 56 Europe Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 57 Europe Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 58 Europe Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 59 Europe Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 60 Europe Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 61 Europe Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 62 Europe Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 63 Europe Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 65 Europe Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 66 Europe Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 70 Asia Pacific Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 71 Asia Pacific Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 72 Asia Pacific Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 73 Asia Pacific Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 74 Asia Pacific Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 75 Asia Pacific Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 76 Asia Pacific Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 77 Asia Pacific Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 78 Asia Pacific Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 79 Asia Pacific Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 80 Asia Pacific Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 81 Asia Pacific Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 82 Asia Pacific Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 83 Asia Pacific Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 84 Asia Pacific Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 85 Asia Pacific Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 87 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 88 Asia Pacific Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 92 South America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 93 South America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 94 South America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 95 South America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 96 South America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 97 South America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 98 South America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 99 South America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 100 South America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 101 South America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 102 South America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 103 South America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 104 South America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 105 South America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 106 South America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 107 South America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 112 South America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 113 South America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 114 Middle East & Africa Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 115 Middle East & Africa Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 116 Middle East & Africa Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 117 Middle East & Africa Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 118 Middle East & Africa Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 119 Middle East & Africa Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 120 Middle East & Africa Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 121 Middle East & Africa Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 122 Middle East & Africa Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 123 Middle East & Africa Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 124 Middle East & Africa Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 125 Middle East & Africa Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 126 Middle East & Africa Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 127 Middle East & Africa Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 128 Middle East & Africa Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 129 Middle East & Africa Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 130 Middle East & Africa Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 131 Middle East & Africa Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 132 Middle East & Africa Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 133 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 134 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 135 Middle East & Africa Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)